Cinven

📢 Our Co-Managing Partner Bruno Schick is joining Moonfare's @Deal Talk on Tuesday 13 October. In conversation with Steffen Pauls, Moonfare's Founder and Co-CEO, Bruno will discuss Cinven's approach to investing and where he sees private markets heading. Topics include: → Exit discipline → The European Opportunity → Working with founder-led businesses → What it takes to build a successful PE firm today Date: Tuesday 13 October 9 am EDT / 2 pm BST / 3 pm CEST Register here: https://lnkd.in/eBub5Wzp

The past couple of weeks have seen great momentum here at Cinven, and we wanted to share a few highlights. 🆕We welcomed Dominic Smyth, who joined as Chief Financial Officer and Chief Operating Officer. We're excited for the experience and energy he is already bringing to the team. 📰We sat down with Alex Heal from the Financial Times, for a wide-ranging conversation which covered our perspectives on the industry, our strong performance momentum, and our pride in our firm and our colleagues. 🔁We were pleased to host our portfolio companies for a Chief Transformation Officer Forum, bringing everyone together to connect, share ideas, and learn from one another. 🎯And we were delighted to share the final close of our second Strategic Fund, “SF2”, raising c. €2.3 billion, exceeding our target fund size by c. 50% and representing a c. 75% increase in fund size versus its predecessor, the Strategic Financials Fund.

We are pleased to announce the final close of our second Strategic Fund, “SF2”, raising c. €2.3 billion, exceeding our target fund size by c. 50% and representing a c. 75% increase in fund size versus its predecessor, the Strategic Financials Fund. Building on the success of our Strategic Financials Fund, the SF2 gives investors access to a differentiated European mid-market strategy, targeting high-growth, asset-light opportunities across Financial Services, Business Services and TMT. The SF2 has already signed four investments: Objectway, Flint Global, Ongoing Warehouse and Optio Group, all of which are performing strongly. We are particularly proud of what Luigi Sbrozzi and Dr. Michael Weber have built, a dedicated team of 16 professionals that has built real conviction to originate four attractive opportunities since launch. Thank you to both our longstanding and new investors for supporting Cinven's European strategy. Read more on the SF2 final close: https://lnkd.in/ekTw5z8v

It’s been a busy few weeks at Cinven, so it feels like a good moment to reflect on our recent activity. At SuperReturn in Berlin we met with many of our valued Limited Partners, and Cinven Partners Alexandra Hess, Dr. Michael Weber and Eleanor Mountain shared their insights on stage. Next, we headed off to Venice for our annual Investment Team offsite, which is always a great chance to get together to address the key opportunities and challenges we see ahead. AI is central to how we invest, from evaluating opportunities to driving value across our portfolio, so this year's offsite was AI-focused, bringing together thought-leaders from the industry, from Cinven's AI specialists to industry experts, including Cinven portfolio company, Artefact, Benedict Evans and Bain & Company. On the investment side, we were pleased to announce that Vitamin Well Group is combining with EMPWR, a leading nutrition bar manufacturer, an exciting next step in Vitamin Well's growth. Our Portfolio team hosted a series of events, including our Procurement team hosting a US portfolio summit and our AI specialist team hosting portfolio sessions; and our Sustainability team published our latest Sustainability Report. Colleagues across our offices also celebrated Pride and took part in industry events. Jorge Quemada Saenz-Badillos and I are particularly proud of our recognition in France, where Cinven was named winner of the Large Cap Investment Fund Award at the Private Equity Magazine Grand Prix. A real highlight! To those taking a break this summer, we hope you get to recharge properly.

We are pleased to announce that Cinven's portfolio company Vitamin Well Group is combining with EMPWR Nutrition Group, a leading nutrition bar manufacturer. EMPWR is a Belgium-headquartered contract development and manufacturing organisation operating four manufacturing facilities across Croatia, the Netherlands, the United States and Canada, with over 1,500 employees and more than 100 customers. EMPWR has been an important manufacturing partner for Vitamin Well, producing the full range of Barebells Original and Soft bars for markets globally. This transaction represents an exciting next step in Vitamin Well's growth trajectory, enabling the Group to further meet the strong consumer demand for its bars. Read more about the transaction of EMPWR: https://lnkd.in/enpvR886

This year, we were honoured to be recognised at the 21st edition of the Private Equity Magazine Grand Prix, taking home the Large Cap Investment Fund Award at the famous Folies Bergère. The recognition reflects a strong year for our team, including investments such as Artefact and Nutrisens, and highlights the continued momentum of our business in France. Congratulations to all those involved.